V. Lánská
-
Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery
Petr Kačer, J. Pirk, V. Lánská, J. A. Hubáček, V. Adámek, T. Červinková, J. Bělohoubek, O. Auzký, V. Adámková
2020, Vol. 66, Issue 4, pp. 148-153 -
Can Leukocyte Telomere Length Predict Survival Time in Heart Transplant Recipients over a Minimal Follow-Up of 20 years?
Dana Dlouhá, V. Vančura, J. Vymětalová, J. A. Hubáček, V. Lánská, I. Málek
2016, Vol. 62, Issue 5, pp. 188-193 -
Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population
Jaroslav A. Hubáček, V. Staněk, M. Gebauerová, R. Poledne, M. Aschermann, H. Skalická, J. Matoušková, A. Kruger, M. Pěnička, H. Hrabáková, J. Veselka, P. Hájek, V. Lánská, V. Adámková, J. Piťha
2012, Vol. 58, Issue 5, pp. 203-208 -
INSIG2 G-102A Promoter Variant Exhibits Context-Dependent Effect on HDL-Cholesterol Levels but Not on BMI in Caucasians
Jaroslav A. Hubáček, P. Suchánek, V. Lánská, J. Piťha, V. Adámková
2011, Vol. 57, Issue 4, pp. 170-172 -
Why We Are Not Able to Find the Coronary Heart Disease Gene – apoE As an Example
Rudolf Poledne, J. A. Hubáček, V. Staněk, M. Aschermann, J. Matoušková, J. Veselka, P. Widimský, R. Cífková, V. Lánská, J. Piťha
2010, Vol. 56, Issue 5, pp. 218-222 -
INSIG2 Promoter Variant, Obesity Markers and Lipid Parameters – No Association in a Large Slavonic Caucasian Population Sample
Jaroslav A. Hubáček, L. Kuthanová, R. Bohuslavová, V. Adámková, V. Lánská, T. Meitinger, A. Pfeufer
2010, Vol. 56, Issue 3, pp. 131-134
